Subscribe to RSS
DOI: 10.1055/s-0034-1378361
Synthesis of 2-Alkynyl 1,3,4-Oxadiazoles by Palladium-Catalyzed Cross- Coupling Reaction[1]
Publication History
Received: 15 April 2014
Accepted after revision: 30 May 2014
Publication Date:
16 July 2014 (online)
Abstract
Several 2-alkynyl 1,3,4-oxadiazoles have been synthesized efficiently by employing palladium-catalyzed cross-coupling under Sonogashira reaction conditions. This reaction has been applied for the first time for the preparation of oxadiazole derivatives. The products were formed in high yields and no side products were detected.
#
Key words
1,3,4-oxadiazole - Sonogashira coupling - palladium-catalyzed reaction - copper(I) iodide - alkynylationOxadiazole derivatives are highly important in pharmaceutical and material sciences. They are used as antimicrobial and anticonvulsant agents.[2] They also act as amide and ester bioisosteres.[3] In addition, substituted oxadiazoles possess multiphoton-absorbing capacities and optoelectronic properties.[4] They are also known to exhibit good electron-transporting and hole-blocking abilities[5] and consequently find application in the development of organic electronics.[6] Herein we report the first application of the Sonogashira reaction[7] for the efficient synthesis of 2-alkynyl 1,3,4-oxadiazoles.
Substituted alkynes are a common unit in natural products and bioactive compounds and are found to be an important feature in various bioactive substances, such as endyne antibiotics.[8] The alkyne moiety can also extend the conjugation of aryl and heteroaryl rings with which it is attached. Thus we realized that 2-alkynyl 1,3,4-oxadiazoles may have bioactivity as well as potential for use in organic materials chemistry.
In continuation of our work[9] on the synthesis of substituted oxadiazoles we discovered that 2-bromo-1,3,4-oxadiazoles (1; readily be prepared from 1,3,4-oxadiazoles[10]) can be subjected to palladium-catalyzed cross-coupling with terminal alkynes under Sonogashira reaction conditions[7] to prepare 2-alkynyl 1,3,4-oxadiazoles (Scheme [1]).
Alkynylation of heterocyclic-based halides using Sonogashira reaction conditions has been frequently employed for the preparation of various novel systems.[11] However, to our knowledge, this reaction has not yet been applied for the generation of oxadiazolyl alkynes (Scheme [1]).


Initially we optimized the reaction conditions with 2-bromo-5-phenyl-1,3,4-oxadiazole (1a) and 2-(4-methylphenyl)acetylene (2a) using various amounts of different palladium catalysts and CuI (Table [1]). Different bases and solvents were also used. In addition, the temperature and the time of the reaction were varied. Considering the yield of the reaction the best result was obtained when PdCl2(PPh3)2 (5mol%), CuI (10 mol%), and Et3N (2 equiv) were used in DMF at 60 °C for six hours (Table [1], entry 1). In the absence of CuI the yield was low (Table [1], entry 6). When the reaction was conducted with other bases (such as Cs2CO3, i-PrNH; Table [1], entries 7 and 8) and other solvents (such as THF, DMSO, dioxane; Table [1], entries 2, 4, and 5) the yield was also low. On increasing the amount of base (Et3N) no significant change in yield was observed (Table [1], entry 9). The reaction was also carried out at room temperature but the reaction time increased and the yield was lower (Table [1], entry 10).
a Reaction conditions: 2-bromo-5-phenyl-1,3,4-oxadiazole 1a (0.7 mmol), 2 (4-methylphenyl) acetylene 2 (1.0 mmol), (PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), base (2.0 equiv), 60–120 °C, 6–36 h, solvent (3 mL).
b Isolated yield of 3 after column chromatography.
c Reaction was carried out at r.t. (27 °C).
d Base (4.0 equiv).
It was also observed that – with other terminal acetylenes other than 2-(4-methylphenyl)acetylene – longer times were required (Table [2]). The conversion also did not proceed smoothly with 2-chloro-1,3,4-oxadiazoles, requiring longer reaction times and resulting in lower yields.
After optimization of the reaction conditions (Table [1]) several 2-alkynyl-1,3,4-oxadiazoles (3) were prepared successfully from various 2-bromo-1,3,4-oxadiazoles 1 and terminal alkynes 2 (Table [2]). The bromooxadiazoles contained different aromatic moieties at C-5 possessing electron-donating as well as electron-withdrawing groups as well as oxygen and nitrogen heterocycles. The terminal alkynes also contained aromatic and heteroaromatic rings at C-2 and even an alkyne with a long aliphatic chain underwent the transformation smoothly (Table [2], entry 6). The products were formed in high yields within 6–16 hours. All the products were characterized from their spectroscopic data and were compared to known compounds.[9] No side reaction including alkyne homocoupling could be observed.
a Reaction conditions: 2-bromo-5-aryl 1,3,4-oxadiazole 1 (0.7 mmol), alkyne 2 (1.0 mmol), (PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), base (2.0 equiv), 60 °C, 6–16 h, DMF (3 mL).
b Isolated yield of 3 after column chromatography.
In conclusion, we have successfully applied the Sonogashira reaction for the first time for the synthesis of a series of 2-alkynyl 1,3,4-oxadiazoles. The products were formed under mild reaction conditions and in high yield.
#
General Experimental Procedure for the Alkynylation of 2-Bromo 1,3,4-Oxadiazoles with Terminal Alkynes
In a 10 mL round-bottom flask under N2 atmosphere, 2-bromo-1,3,4-oxadiazole (0.7 mmol), alkyne (1.0 mmol), PdCl2(PPh3)2 (5 mol%), CuI (10 mol%), and Et3N (2.0 equiv) in anhydrous DMF (2.0 mL) were combined. The reaction mixture was stirred at 60 °C for 6–16 h, and progress of reaction was monitored by TLC. After the consumption of the starting materials, the reaction mixture was allowed to cool, and subsequently extracted with Et2O (2 × 15 mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo followed by flash chromatography on silica to afford the corresponding 2-alkynyl-1,3,4-oxadiazole in good yield.
#
Selected Spectroscopic Data
#
2-Phenyl-5-(p-tolylethynyl)-1,3,4-oxadiazole (3ab)
IR (neat): 2215, 1601, 1533, 1476, 1279 cm–1. 1H NMR (200 MHz, CDCl3): δ = 8.09 (2 H, d, J = 8.0 Hz), 7.56–7.48 (5 H, m), 7.22 (2 H, d, J = 8.0 Hz), 2.41 (3 H, s). 13C NMR (50 MHz, CDCl3): δ = 164.9, 150.9, 141.2, 132.8, 132.7, 129.3, 129.0, 127.1, 123.4, 116.8, 97.6, 72.8, 21.8. ESI-MS: m/z = 283 [M + Na]+. ESI-HRMS: m/z calcd for C17H12N2ONa [M + Na]+: 283.0847; found: 283.0849.
#
2-Phenyl-5-(thiophen-2-ylethynyl)-1,3,4-oxadiazole (3af)
IR (neat): 2211, 1544, 1478, 1411, 1211 cm–1. 1H NMR (200 MHz, CDCl3): δ = 8.13–8.09 (2 H, m), 7.59–7.46 (5 H, m), 7.10 (1 H, m). 13C NMR (50 MHz, CDCl3): δ = 165.0, 150.9, 135.5, 132.2, 131.0, 129.1, 127.3, 127.1, 126.9, 123.5, 91.0, 77.1; ESI-MS: m/z 253 [M + H]+, 275 [M + Na]+. ESI-HRMS: m/z calcd for C14H8N2OSNa [M + Na]+: 275.0255; found: 275.0250.
#
2-(Non-1-ynyl)-5-phenyl-1,3,4-oxadiazole (3ag)
IR (neat): 2223, 1584, 1451, 1250 cm–1. 1H NMR (200 MHz, CDCl3): δ = 8.08–7.98 (2 H, m), 7.58–7.44 (3 H, m), 2.59 (2 H, t, J = 8.0 Hz), 1.79–1.70 (2 H, m), 1.59–1.51 (2 H, m), 1.48–1.32 (6 H, m), 0.96 (3 H, t, J = 7.0 Hz). 13C NMR (50 MHz, CDCl3): δ = 161.5, 151.9, 131.9, 129.1, 127.9, 126.8, 98.0, 62.9, 33.2, 30.1, 30.0, 29.9, 22.9, 18.0, 13.2. ESI-MS: m/z 291 [M + Na]+. ESI-HRMS: m/z calcd for C17H20N2ONa [M + Na]+: 291.0689; found: 291.0685.
#
2-(Naphthalen-1-ylethynyl)-5-p-tolyl-1,3,4-oxadiazole (3be)
IR (neat): 2215, 1612, 1532, 1491, 1195 cm–1. 1H NMR (200 MHz, CDCl3): δ = 8.40 (1 H, d, J = 8.0 Hz), 8.04 (2 H, d, J = 8.0 Hz), 7.98–7.85 (3 H, m), 7.70–7.48 (3 H, m), 7.31 (2 H, d, J = 8.0 Hz), 2.43 (3 H, s). 13C NMR (50 MHz, CDCl3): δ = 165.0, 150.6, 143.0, 133.0, 132.9, 132.2, 131.4, 130.0, 128.8, 127.9, 127.1, 127.0, 125.9, 125.2, 120.8, 117.6, 95.5, 77.8, 21.4. ESI-MS: m/z = 311 [M + H]+. ESI-HRMS: m/z calcd for C21H15N2O [M + H]+ 311.1184; found: 311.1178.
#
#
Acknowledgment
The authors thank UGC and CSIR, New Delhi for financial assistance.
-
References and Notes
- 1 Part 236 in the series ‘Studies on novel synthetic methodologies’.
- 2a Rostom SA. F, Shalaby MA, El-Demellawy MA. Eur. J. Med. Chem. 2003; 38: 959
- 2b Jha KK, Samad A, Kumar Y, Shaharyar M, Khosa RL, Jain J, Kumar V, Sing P. Eur. J. Med. Chem. 2010; 45: 4963
- 2c Singh P, Jangra PK. Der Chemica Sinica 2010; 1: 118
- 3 Leung D, Du W, Hardouin C, Cheng H, Hwang I, Cravatt BF, Boger DL. Bioorg. Med. Chem. Lett. 2005; 15: 1423
- 4a He GS, Tan L-S, Zheng Q, Prasad PN. Chem. Rev. 2008; 108: 1245
- 4b Guin S, Ghosh T, Rout SK, Banarjee A, Patel BK. Org. Lett. 2011; 13: 5976
- 5 Singh S, Sharma LK, Saraswat A, Siddiqui IR, Kheri HK, Singh RK. P. RSC Adv. 2013; 3: 4237
- 6a Mitschke U, Bauerle P. J. Mater. Chem. 2000; 10: 1471
- 6b Zarudnitskii EV, Pervak II, Merkulov AS, Yurchenko AA, Tolmachev AA. Tetrahedron 2008; 64: 10431
- 7a Thorand S, Krause N. J. Org. Chem. 1998; 63: 8551
- 7b Hundertmark T, Litter AF, Buchwald SL, Fu GC. Org. Lett. 2000; 2: 1729
- 7c Chow H.-F, Wan C.-W, Low K.-H, Yeung Y.-Y. J. Org. Chem. 2001; 66: 1910
- 7d Sonogashira K. J. Organomet. Chem. 2002; 653: 46
- 7e Eberhard MR, Wang Z, Jensen CM. Chem. Commun. 2002; 818
- 7f Choudary BM, Madhi S, Chowdari NS, Kantam ML, Sreedhar B. J. Am. Chem. Soc. 2002; 124: 14127
- 7g Kollhofer A, Pullmann T, Plenio H. Angew. Chem. 2003; 115: 1086
- 7h Hierso J.-C, Fihri A, Amardeil R, Meunier P. Org. Lett. 2004; 6: 3473
- 7i Son SU, Jang Y, Park J, Na HB, Park HM, Yun HJ, Lee J, Hyeon T. J. Am. Chem. Soc. 2004; 126: 5026
- 7j Feuerstein M, Doucet H, Santelli M. Tetrahedron Lett. 2004; 45: 8443
- 8a Tykwinski RR. Angew. Chem. Int. Ed. 2003; 42: 1566
- 8b Lu L, Yan H, Sun P, Zhu Y, Yang H, Liu D, Rong G, Mao J. Eur. J. Org. Chem. 2013; 1644
- 9a Reddy GC, Balasubramanyam P, Salvanna N, Das B. Eur. J. Org. Chem. 2012; 471
- 9b Das B, Reddy GC, Balasubramanyam P, Salvanna N. Tetrahedron 2012; 68: 300
- 9c Salvanna N, Reddy GC, Das B. Tetrahedron 2013; 69: 2220
- 9d Salvanna N, Reddy GC, Rao BR, Das B. RSC Adv. 2013; 3: 20538
- 10 Boga C, Del Vecchio E, Forlani L, Todesco PE. J. Organomet. Chem. 2000; 601: 233
- 11a Gelman D, Buchwald SL. Angew. Chem. Int. Ed. 2003; 42: 5993
- 11b Doucet H, Hierso JC. Angew. Chem. Int. Ed. 2007; 46: 834
- 11c Wolff O, Waldvogel SR. Synthesis 2007; 761
- 11d Chinchilla R, Najera C. Chem. Rev. 2007; 107: 874
- 11e Ullah F, Dang TT, Heinicke J, Villiger A, Langer P. Synlett 2009; 838
- 11f Manarin F, Roehrs JA, Branda O, Nogueira CW, Zeni G. Synthesis 2009; 4001
- 11g Sajith AM, Muralidharan A. Tetrahedron Lett. 2012; 53: 5206
-
References and Notes
- 1 Part 236 in the series ‘Studies on novel synthetic methodologies’.
- 2a Rostom SA. F, Shalaby MA, El-Demellawy MA. Eur. J. Med. Chem. 2003; 38: 959
- 2b Jha KK, Samad A, Kumar Y, Shaharyar M, Khosa RL, Jain J, Kumar V, Sing P. Eur. J. Med. Chem. 2010; 45: 4963
- 2c Singh P, Jangra PK. Der Chemica Sinica 2010; 1: 118
- 3 Leung D, Du W, Hardouin C, Cheng H, Hwang I, Cravatt BF, Boger DL. Bioorg. Med. Chem. Lett. 2005; 15: 1423
- 4a He GS, Tan L-S, Zheng Q, Prasad PN. Chem. Rev. 2008; 108: 1245
- 4b Guin S, Ghosh T, Rout SK, Banarjee A, Patel BK. Org. Lett. 2011; 13: 5976
- 5 Singh S, Sharma LK, Saraswat A, Siddiqui IR, Kheri HK, Singh RK. P. RSC Adv. 2013; 3: 4237
- 6a Mitschke U, Bauerle P. J. Mater. Chem. 2000; 10: 1471
- 6b Zarudnitskii EV, Pervak II, Merkulov AS, Yurchenko AA, Tolmachev AA. Tetrahedron 2008; 64: 10431
- 7a Thorand S, Krause N. J. Org. Chem. 1998; 63: 8551
- 7b Hundertmark T, Litter AF, Buchwald SL, Fu GC. Org. Lett. 2000; 2: 1729
- 7c Chow H.-F, Wan C.-W, Low K.-H, Yeung Y.-Y. J. Org. Chem. 2001; 66: 1910
- 7d Sonogashira K. J. Organomet. Chem. 2002; 653: 46
- 7e Eberhard MR, Wang Z, Jensen CM. Chem. Commun. 2002; 818
- 7f Choudary BM, Madhi S, Chowdari NS, Kantam ML, Sreedhar B. J. Am. Chem. Soc. 2002; 124: 14127
- 7g Kollhofer A, Pullmann T, Plenio H. Angew. Chem. 2003; 115: 1086
- 7h Hierso J.-C, Fihri A, Amardeil R, Meunier P. Org. Lett. 2004; 6: 3473
- 7i Son SU, Jang Y, Park J, Na HB, Park HM, Yun HJ, Lee J, Hyeon T. J. Am. Chem. Soc. 2004; 126: 5026
- 7j Feuerstein M, Doucet H, Santelli M. Tetrahedron Lett. 2004; 45: 8443
- 8a Tykwinski RR. Angew. Chem. Int. Ed. 2003; 42: 1566
- 8b Lu L, Yan H, Sun P, Zhu Y, Yang H, Liu D, Rong G, Mao J. Eur. J. Org. Chem. 2013; 1644
- 9a Reddy GC, Balasubramanyam P, Salvanna N, Das B. Eur. J. Org. Chem. 2012; 471
- 9b Das B, Reddy GC, Balasubramanyam P, Salvanna N. Tetrahedron 2012; 68: 300
- 9c Salvanna N, Reddy GC, Das B. Tetrahedron 2013; 69: 2220
- 9d Salvanna N, Reddy GC, Rao BR, Das B. RSC Adv. 2013; 3: 20538
- 10 Boga C, Del Vecchio E, Forlani L, Todesco PE. J. Organomet. Chem. 2000; 601: 233
- 11a Gelman D, Buchwald SL. Angew. Chem. Int. Ed. 2003; 42: 5993
- 11b Doucet H, Hierso JC. Angew. Chem. Int. Ed. 2007; 46: 834
- 11c Wolff O, Waldvogel SR. Synthesis 2007; 761
- 11d Chinchilla R, Najera C. Chem. Rev. 2007; 107: 874
- 11e Ullah F, Dang TT, Heinicke J, Villiger A, Langer P. Synlett 2009; 838
- 11f Manarin F, Roehrs JA, Branda O, Nogueira CW, Zeni G. Synthesis 2009; 4001
- 11g Sajith AM, Muralidharan A. Tetrahedron Lett. 2012; 53: 5206



